META vs NBIS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
META exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial strength across profitability, leverage, and operating efficiency. While the current price of $612.42 trades at a premium to the Graham Number ($213.17) and the growth-based Intrinsic Value ($542.14), the PEG ratio of 0.94 suggests the stock is undervalued relative to its high growth rate. Strong revenue growth (23.8%) and a low forward P/E (17.03) outweigh the bearish technical trend and insider selling. The company's dominant market position and consistent earnings beats support a bullish long-term outlook.
NBIS exhibits a stable financial health profile with a Piotroski F-Score of 6/9, yet it suffers from a catastrophic valuation disconnect. The stock trades at $161.94, vastly exceeding its Graham Number ($6.72) and Intrinsic Value ($0.77), with an astronomical P/E ratio of 1472.18. While revenue growth is hyper-accelerated at 500.80% YoY, the company is burning cash aggressively with an operating margin of -102.99%. Combined with bearish insider selling from the CEO and CTO, the current price appears to be driven by speculative momentum rather than fundamental value.
Compare Another Pair
Related Comparisons
META vs NBIS: Head-to-Head Comparison
This page compares Meta Platforms, Inc. (META) and Nebius Group N.V. (NBIS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.